Innovating bioengineering solutions for our future using our deep understanding of complex microfluidic devices
Microfluidics at high particle concentrations (> 1 vol%) are not very well understood due to complex particle-particle interaction. We have developed a Dense Suspension Inertial Microfluidics Theory (DENSE-IMPACT) Simulation that can accurately model inertial microfluidics at high particle concentrations.
In the area of dense suspension microfluidics, we have made a new scientific discovery, which eventually led to an invention which has been described as “disruptive” by a big biopharmaceutical company. We intend to spin-off a company based on this invention and have developed a minimum viable product (MVP) that is currently being evaluated in a biopharmaceutical MNC in USA.
We have utilized our capabilities in designing complex microbioreactors for organ-on-a-chip applications. Shown here is our proprietary uBioChipX model for Gut Microbiome studies integrating anaerobic gut microbiome with primary gut epithelial cells on Transwells and oxygenated immune cells below.
We will be developing a space bioreactor integrated with real-time sensors and feedback control for intelligent feeding. We will also be developing a similar bioreactor for microgravity experiments for rapid aging testing of novel anti-aging drugs.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.